Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other?

Published:2019-10-24 Issue:3 Volume:107 Page:507-513
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Teixeira Tania¹,Kweder Sandra L.²^ORCID,Saint‐Raymond Agnes¹^ORCID

Affiliation:

1. International Affairs Division European Medicines Agency Amsterdam The Netherlands

2. Europe Office US Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1617

Reference12 articles.

1. International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use. . Accessed March 15 2019.

2. International Conference of Drug Regulatory Authorities (ICDRA). . Accessed July 8 2019.

3. International Coalition of Medicines Regulatory Authorities (ICMRA). . Accessed July 8 2019.

4. European Medicines Agency.International Partners. Accessed March 15 2019.

5. European Medicines Agency.Confidentiality arrangements. . Accessed July 19 2019.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Post‐Marketing Requirements for Orphan Drugs: A Cross‐Sectional Analysis of FDA and EMA Oversight;Clinical Pharmacology & Therapeutics;2024-08-28

2. From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt;Pharmaceuticals;2024-07-03

3. A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data;Journal of Diabetes Investigation;2024-06-29

4. Innovations in Healthcare;Advances in Medical Technologies and Clinical Practice;2024-06-14

5. Beyond the adverse effects of the systemic route: Exploiting nanocarriers for the topical treatment of skin cancers;Advanced Drug Delivery Reviews;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3